blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1265073

EP1265073 - Methods for determining plasma free drug concentration [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.08.2008
Database last updated on 24.01.2025
Most recent event   Tooltip01.08.2008Application deemed to be withdrawnpublished on 03.09.2008  [2008/36]
Applicant(s)For all designated states
Tibotec Pharmaceuticals Ltd.
Eastgate Village Eastgate Little Island
Co Cork / IE
[2006/46]
Former [2002/50]For all designated states
Tibotec Pharmaceuticals Ltd.
Unit 4, Block 4B, Blanchardstown Corporate Park
Blanchardstown, Dublin 15 / IE
Inventor(s)01 / Xie, Dong
13944 Bromfield Road
Germantown, Midland 20874 / US
02 / Cao, Wei
62 Oneida Avenue
Centereach, New York 11720 / US
03 / Erickson, John W.
5406 Jefferson Boulevard
Frederick, Midland 21703 / US
 [2002/50]
Representative(s)Daelemans, Frank F.R., et al
Tibotec-Virco N.V., Generaal De Wittelaan L11 B3
B-2800 Mechelen / BE
[N/P]
Former [2002/50]Daelemans, Frank F.R., et al
Tibotec-Virco N.V., General De Wittelaan L11 B3
B-2800 Mechelen / BE
Application number, filing date02077275.205.06.2002
[2002/50]
Priority number, dateUS20010295557P05.06.2001         Original published format: US 295557 P
[2002/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1265073
Date:11.12.2002
Language:EN
[2002/50]
Type: A3 Search report 
No.:EP1265073
Date:26.11.2003
[2003/48]
Search report(s)(Supplementary) European search report - dispatched on:EP10.10.2003
ClassificationIPC:G01N33/94, G01N33/569, G01N33/68, C12Q1/37
[2003/47]
CPC:
G01N33/566 (EP,US); C12Q1/18 (EP,US); G01N33/94 (EP,US);
G01N2500/02 (EP,US)
Former IPC [2002/50]G01N33/94, G01N33/569, G01N33/68
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/50]
TitleGerman:Verfahren zum Nachweis von der Plasmakonzentration von freien Arzneimitteln[2002/50]
English:Methods for determining plasma free drug concentration[2002/50]
French:Procédé de détermination des concentrations des drogues libres dans le plasma[2002/50]
Examination procedure26.05.2004Examination requested  [2004/31]
02.11.2007Despatch of a communication from the examining division (Time limit: M04)
13.03.2008Application deemed to be withdrawn, date of legal effect  [2008/36]
16.04.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/36]
Fees paidRenewal fee
30.06.2004Renewal fee patent year 03
30.06.2005Renewal fee patent year 04
30.06.2006Renewal fee patent year 05
02.07.2007Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.06.200807   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9708180  (UNIV ALABAMA [US], et al) [A] 1-19 * claims 7,21 *;
 [PA]WO0140758  (UNIV JOHNS HOPKINS [US]) [PA] 2,19* page 3 *;
 [A]  - JONES K ET AL, "Effect of alpha1-acid glycoprotein on the intracellular accumulation of the HIV protease inhibitors saquinavir, ritonavir and indinavir in vitro.", BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, (200101), vol. 51, no. 1, ISSN 0306-5251, pages 99 - 102, XP002252517 [A] * page 99 * * page 101, column L, paragraph 2 - page 101, column R, paragraph 1 *

DOI:   http://dx.doi.org/10.1046/j.1365-2125.2001.01324.x
 [A]  - VELAZQUEZ-CAMPOY ADRIAN ET AL, "HIV-1 protease inhibitors: Enthalpic versus entropic optimization of the binding affinity.", BIOCHEMISTRY, (20000307), vol. 39, no. 9, ISSN 0006-2960, pages 2201 - 2207, XP002254944 [A] 1-19 * page 2201 - page 2203 *

DOI:   http://dx.doi.org/10.1021/bi992399d
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.